International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small ...
(MENAFN- iCrowdNewsWire) size is forecast to reach $378.4 billion by 2026, growing at a CAGR of 9.9% during the forecast period 2021-2026. Pathological examination is a complex process that involves ...
A team of researchers has created a digital pathology platform based on artificial intelligence. The platform uses new algorithms developed by the team and enables fully automated analysis of tissue ...
Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results